Century Therapeutics Appointed Brent Pfeiffenberger As CEO And Member Of The Board Replacing Interim CEO Greg Russotti, Effective December 4, 2023
Portfolio Pulse from Benzinga Newsdesk
Century Therapeutics has announced the appointment of Brent Pfeiffenberger as its new CEO and board member, effective from December 4, 2023. He will replace the interim CEO Greg Russotti.
November 09, 2023 | 12:20 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
The appointment of a new CEO at Century Therapeutics, a company related to iPS Academia Japan, Inc. (IPSC), may have indirect implications for IPSC.
The appointment of a new CEO at Century Therapeutics could bring about changes in the company's strategy and operations, which may indirectly affect iPS Academia Japan, Inc. (IPSC) due to their relationship. However, the direct impact on IPSC is uncertain at this point.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 50